Evidence map›Paper›PMID 37022136›Full record

ArticleeLife2023

Characterisation of an

Samantha D M Arras, Nellie Sibaeva, Ryan J Catchpole, Nobuyuki Horinouchi, Dayong Si, Alannah M Rickerby, Kengo Deguchi, Makoto Hibi, Koichi Tanaka, Michiki Takeuchi and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Samantha D M ArrasSchool of Biological Sciences, University of Auckland, Auckland, New Zealand.ORCID 0009-0003-7544-6007
Nellie SibaevaSchool of Biological Sciences, University of Auckland, Auckland, New Zealand.
Ryan J CatchpoleSchool of Biological Sciences, University of Canterbury, Christchurch, New Zealand.ORCID 0000-0001-6641-647X
Nobuyuki HorinouchiDivision of Applied Life Sciences,Graduate School of Agriculture, Kyoto University, Kyoto, Japan.
Dayong SiDivision of Applied Life Sciences,Graduate School of Agriculture, Kyoto University, Kyoto, Japan.
Alannah M RickerbySchool of Biological Sciences, University of Auckland, Auckland, New Zealand.
Kengo DeguchiDivision of Applied Life Sciences,Graduate School of Agriculture, Kyoto University, Kyoto, Japan.
Makoto HibiDivision of Applied Life Sciences,Graduate School of Agriculture, Kyoto University, Kyoto, Japan.
Koichi TanakaDivision of Applied Life Sciences,Graduate School of Agriculture, Kyoto University, Kyoto, Japan.
Michiki TakeuchiDivision of Applied Life Sciences,Graduate School of Agriculture, Kyoto University, Kyoto, Japan.
Jun OgawaDivision of Applied Life Sciences,Graduate School of Agriculture, Kyoto University, Kyoto, Japan.ORCID 0000-0003-2741-621X
Anthony M PooleSchool of Biological Sciences, University of Auckland, Auckland, New Zealand.ORCID 0000-0001-9940-2824
Kyoto University · JPUniversity of Auckland · NZUniversity of Canterbury · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Life requires ribonucleotide reduction for de novo synthesis of deoxyribonucleotides. As ribonucleotide reduction has on occasion been lost in parasites and endosymbionts, which are instead dependent on their host for deoxyribonucleotide synthesis, it should in principle be possible to knock this process out if growth media are supplemented with deoxyribonucleosides. We report the creation of a strain of

Indexed as

Ribonucleotide ReductasesRibonucleotidesDeoxyribonucleosidesDeoxyribonucleotidesEscherichia coliSymbiosisDeoxyribonucleosidesDeoxyribonucleotidesRibonucleotide ReductasesRibonucleotidesdeoxyribonucleotide synthesisE. coliendosymbiosisevolutionary biologyinfectious diseaseintracellularitymicrobiologyphosphopentomutaseribonucleotide reduction

Identifiers

PMID37022136
PMCPMC10121223
OpenAlexW4362657525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.